Switch to:
More From Other Websites
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
20 dividend stocks that Wall Street loves the most Feb 05 2016
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink Feb 04 2016
Factors of Influence in Today's Market - Analyst Notes on General Motors, AbbVie, Yum! Brands and... Feb 04 2016
The Real Risks of Gilead’s Stock Feb 03 2016
Seven $1 billion-plus drugs seen reaching market in 2016 Feb 03 2016
Gilead Q4 Earnings Beat Estimates; Guidance In Line With Street Feb 02 2016
AbbVie, Inc. Earnings Analysis: Q4, 2015 By the Numbers Feb 02 2016
Gilead Sciences: 'An Increasingly Tight Hep C Space Moving Forward,' Guggenheim Says Feb 01 2016
[$$] Gilead risks becoming victim of its own success Jan 31 2016
AbbVie Reports Mixed Q4 As Merck Launches Rival HCV Treatment Jan 29 2016
3 Health Care Stocks to Own in a Dangerous Market Jan 29 2016
Payers see price leverage with entry of Merck hepatitis C drug Jan 29 2016
AbbVie Posts In-Line Earnings, Maintains 2016 Outlook Jan 29 2016




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK